跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Indazole 1
首页
药物
Indazole 1
Indazole 1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF
EP 4479394 A1
申请人: FMC CORP
优先权: 2022
CN
EP
US
WO
12 件公开
Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required magnesium intermediates
US 8354544 B2
申请人: ACRAF
优先权: 2009
CN
US
6 件公开
1-substituted indazole derivative
US 8765786 B2
申请人: DAINIPPON SUMITOMO PHARMA CO
优先权: 2012
US
6 件公开
CRYSTALLINE 2-AMINO-2-(HYDROXYMETHYL)PROPANE-1,3-DIOL SALT OF 4-(4-(1-ISOPROPYL-7-OXO-1,4,6,7-TETRAHYDROSPIRO[INDAZOLE-5,4'-PIPERIDINE]-1'-CARBONYL)-6-METHOXYPYRIDIN-2-YL)BENZOIC ACID
EP 3713942 B8
申请人: PFIZER
优先权: 2017
CN
EP
US
WO
5 件公开
NOVEL INDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF
US 20260167629 A1
申请人: KOREA UNIV RESEARCH AND BUSINESS FOUNDATION
优先权: 2022
CN
EP
US
WO
4 件公开
1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
US 6995176 B2
申请人: WYETH CORP
优先权: 2003
US
4 件公开
N-(IMIDAZO[1,2-B]PYRIDAZIN-3-YL)-1-CYCLOHEXYL-2H-INDAZOLE-5-CARBOXAMIDE AND N-(PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-1-CYCLOHEXYL-2H-INDAZOLE-5-CARBOXAMIDE DERIVATIVES AS IRAK4 INHIBITORS FOR THE TREATMENT OF ASTHMA
EP 4259632 B1
申请人: ASTRAZENECA AB
优先权: 2020
CN
EP
WO
3 件公开
CRYSTALLINE IRAK4 INHIBITORS
EP 4758137 A1
申请人: ASTRAZENECA AB
优先权: 2023
CN
EP
WO
3 件公开
Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
US 8754209 B2
申请人: SIM TAE BO
优先权: 2008
CN
US
3 件公开
Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
US 8623862 B2
申请人: BADORC ALAIN
优先权: 2011
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈